137
Voyager Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
124
FY23:
320
FY24:
277
FY25:
203
(positive)
Change from FY21 to FY25
millions USD
FY21:
57.2
FY22:
34.9
FY23:
31.6
FY24:
116
FY25:
49.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
194
FY22:
159
FY23:
351
FY24:
393
FY25:
252
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
51.0
FY22:
72.6
FY23:
64.5
FY24:
49.8
FY25:
26.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
47.8
FY22:
27.7
FY23:
50.5
FY24:
43.5
FY25:
29.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
95.1
FY22:
59.0
FY23:
236
FY24:
300
FY25:
196
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
194
FY22:
159
FY23:
351
FY24:
393
FY25:
252
All amounts in millions USD